We found that patients who achieved CR/PR before CAR-T in the t-FL group had a better PFS ( P = 0.09), while other parameters did not reach statistical significance.
← all excerpts
A retrospective cohort study of chimeric antigen receptor T-Cell therapy in follicular lymphoma patients with or without histological transformation.
1
—
—